The uncertainty of treatment: Women's use of HIV treatment as prevention in Malawi
Section snippets
Barriers to adherence
Public health research has explored how and why HIV-positive women use treatment. Scholars focus on identifying the myriad of potential factors that prevent patients from taking prescribed treatment. The list of barriers for HIV-positive women is comprehensive; it ranges from individual to community and institutional level factors, including: insufficient knowledge of HIV/ART, fear of treatment, religious beliefs, poor drug management, difficulty in reaching the clinic, HIV stigma, fear of
Context and methods
Malawi is one of the poorest and least developed countries in the world. It is ranked 173 of 188 countries on the Human Development Index, and more than half the population (72%) survives on less than US$1.25 dollars a day (United Nations Development Programme, 2015). 16.7% of children under five are considered underweight (2 standard deviations below the international median), and 42% experience stunted growth from chronic malnutrition (World Bank, 2015). In addition, Malawi is ravaged by the
The uncertainty of treatment
Treatment decisions are neither static nor permanent. By the time of the interview, many women had already changed their decision. About half of the women who initially accepted ART stopped for some time (26/55). Of the women who initially refused, about half started treatment later (4/10), and of the women who stopped, about half started treatment again (16/26). On average, women stopped ART during pregnancy for a few months before starting again, though the length of time varied widely,
Finding the benefit of ART
Echoing research on illness experience, women construct narratives about what caused the onset of illness, what the early signs were, and what affect it is having on their lives (see Pierret, 2003). For some women, the benefit of ART was apparent when they interpreted past illnesses as signs of HIV infection and medication led to improvements in their physical condition. Not only did this fit their conception of what medication should do, it also provided economic benefits since improved health
Self-regulation
The benefits of ART were not clear to all women. For some, treatment led to worse, rather than better, health outcomes. While they did not have symptoms before starting treatment, they clearly experienced symptoms of sickness after taking ART from side effects, such as dizziness, vomiting, and sleep disruption. Women felt confused and questioned whether ART is working properly. Amidst the uncertainty of an unseen and unfelt disease is the tangible sickness caused by the medicine itself.
Women
Political economy of taking ART
Women's embodied experience of ART is related to their broader economic circumstances. Living situations in Malawi are constantly in flux. At some point, a woman might be married, have piecework, and a good harvest, while at other times, she might find herself divorced and depending on family for basic needs. Many women and their husbands did not have consistent work, and they sometimes had to sell land and other goods to buy food. One woman describes her situation after her husband lost his
Conclusion
This article describes how women in Malawi make decisions about taking HIV treatment. Women are told to start treatment often before they have symptoms and may experience side effects that make them feel worse than before. They look for evidence of the drug's efficacy based on their experiences with sickness and drug-taking. For some women, the benefits of ART lined up neatly. Treatment had both physical and material benefits; they felt healthier and more productive at work after taking ART.
Acknowledgements
I would like to thank Stefan Timmermans, Susan Watkins, CK Lee, Edward Walker, Caroline Tietbohl, Saskia Nauenberg, Marie Berry, Tom Hannan, Juan Delgado, and Leydy Diossa for providing helpful comments on earlier versions of this article. I also appreciate feedback from members of the UCLA Health Working Group and the anonymous reviewers of Social Science & Medicine. I am very grateful to my Malawian research assistant and the participants who shared their stories with us. I received valuable
References (67)
Working outside of the box: how HIV counselors in sub-Saharan Africa adapt Western HIV testing norms
Soc. Sci. Med.
(2010)- et al.
Medicalization and pharmaceuticalization at the intersections: looking backwards, sideways and forward
Soc. Sci. Med.
(2012) The meaning of medications: another look at compliance
Soc. Sci. Med.
(1985)Local demand for a global intervention: policy priorities in the time of AIDS
World Dev.
(2012)- et al.
Patient non-compliance: deviance or reasoned decision-making?
Soc. Sci. Med.
(1992) - et al.
Does global health funding respond to recipients“ needs? comparing public and private donors” allocations in 2005-2007
World Dev.
(2011) Patient resistance as agency in treatment decisions
Soc. Sci. Med.
(2011)Fishing in dangerous waters: ecology, gender and economy in HIV risk
Soc. Sci. Med.
(2011)- et al.
Resisting medicines: a synthesis of qualitative studies of medicine taking
Soc. Sci. Med.
(2005) - et al.
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach
Lancet
(2011)